Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids

Clinical Biochemistry

Volumn 40, Issue 1-2, 2007, Pages 104-110

  Shaw, Julie L V ^a,b   Grass, Linda ^a   Sotiropoulou, Georgia ^c   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF PATRAS   (Greece)

Author keywords

Immunoassay; Kallikrein; KLK15; Serine proteases; Tissue expression

Indexed keywords

KALLIKREIN; KALLIKREIN 15; MESSENGER RNA; POLYCLONAL ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BODY FLUID; BREAST MILK; CHROMATOGRAPHY; COLON; CONTROLLED STUDY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNIZATION; IMMUNOFLUOROMETRY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROSTATE; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; RABBIT; SEMINAL PLASMA; SENSITIVITY ANALYSIS; TISSUE DISTRIBUTION; TISSUE LEVEL;

AMINO ACID SEQUENCE; AMNIOTIC FLUID; ANTIBODIES; BLOTTING, WESTERN; BODY FLUIDS; CALIBRATION; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUOROIMMUNOASSAY; GLYCOSYLATION; HUMANS; KALLIKREINS; MASS SPECTROMETRY; MILK, HUMAN; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDES; RECOMBINANT PROTEINS; SEMEN;

EID: 33845781630     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.07.011     Document Type: Article

References (23)

1. Yousef G.M., and Diamandis E.P. The new human tissue kallikrein gene family: structure, function, and association to disease. Endocr. Rev. 22 (2001) 184-204
2. Clements J.A., Willemsen N.M., Myers S.A., and Dong Y. The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit. Rev. Clin. Lab. Sci. 41 (2004) 265-312
3. Yousef G.M., Scorilas A., Jung K., Ashworth L.K., and Diamandis E.P. Molecular cloning of the human kallikrein 15 gene (KLK15). J. Biol. Chem. 276 (2001) 53-61
4. Takayama T.K., Carter C.A., and Deng T. Activation of prostate-specific antigen precursor (pro-PSA) by prostin, a novel human prostatic serine protease identified by degenerate PCR. Biochemistry 40 (2001) 1679-1687
5. Sotiropoulou G., Rogakos V., Tsetsenis T., Pampalakis G., Zafiropoulos N., Simillides G., et al. Emerging interest in the kallikrein gene family for understanding and diagnosing cancer. Oncol. Res. 13 (2003) 381-391
6. Yousef G.M., and Diamandis E.P. Human tissue kallikreins: a new enzymatic cascade pathway?. Biol. Chem. 383 (2002) 1045-1057
7. Borgono C.A., and Diamandis E.P. The emerging roles of human tissue kallikreins in cancer. Nat. Rev., Cancer 4 (2004) 876-890
8. Diamandis E.P., and Yousef G.M. Human tissue kallikreins: a family of new cancer biomarkers. Clin. Chem. 48 (2002) 1198-1205
9. McCormack R.T., Rittenhouse H.G., Finlay J.A., Sokoloff R.L., Wang T.J., Wolfert R.L., et al. Molecular forms of prostate-specific antigen and the human kallikrein gene family: a new era. Urol. 45 (1995) 729-744
10. Rittenhouse H.G., Finlay J.A., Mikolajczyk S.D., and Partin A.W. Human kallikrein 2 (hK2) and prostate-specific antigen (PSA): two closely related, but distinct, kallikreins in the prostate. Crit. Rev. Clin. Lab. Sci. 35 (1998) 275-368
11. Stephan C., Yousef G.M., Scorilas A., Jung K., Jung M., Kristiansen G., et al. Quantitative analysis of kallikrein 15 gene expression in prostate tissue. J. Urol. 169 (2003) 361-364
12. Yousef G.M., Scorilas A., Katsaros D., Fracchioli S., Iskander L., Borgono C., et al. Prognostic value of the human Kallikrein 15 gene expression in ovarian cancer. J. Clin. Oncol. 21 (2003) 3119-3126
13. Yousef G.M., Scorilas A., Magklara A., Memari N., Ponzone R., Sismondi P., et al. The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer. Br. J. Cancer 87 (2002) 1294-1300
14. Luo L.Y., Grass L., Howarth D.J., Thibault P., Ong H., and Diamandis E.P. Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues. Clin. Chem. 47 (2001) 237-246
15. Christopoulos T.K., and Diamandis E.P. Enzymatically amplified time-resolved fluorescence immunoassay with terbium chelates. Anal. Chem. 64 (1992) 342-346
16. Memari N., Grass L., Nakamura T., Karakucuk I., and Diamandis E.P. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies. Biol. Chem. 387 (2006) 733-740
17. Yu H., and Diamandis E.P. Ultrasensitive time-resolved immunofluorometric assay of prostate specific antigen in serum and preliminary clinical studies. Clin. Chem. 387 (2006) 733-740
18. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP, Ultrasensitive detection of prostate-specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. 1996;42:675-684.
19. 1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostate cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res. 51 (1991) 222-226
20. 1-antichymotrypsin. Clin. Chem. 37 (1991) 1618-1627
21. 2-antichymotrypsin. Clin. Chem. 44 (1998) 2471-2479
22. 1-antichymotrypsin. Clin. Chem. 49 (2003) 746-751
23. Yousef G.M., Kapadia C., Polymeris M.C., Borgono C., Hutchinson S., Wasney G.A., et al. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids. Biochim. Biophys. Acta 1628 (2003) 88-96